Roche NimbleGen Introduces Advanced RNA-Seq Target Enrichment Tools for In-Depth Transcriptome Studies
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the launch of the SeqCap RNA Target Enrichment System for RNA-Seq applicati…
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the launch of the SeqCap RNA Target Enrichment System for RNA-Seq applicati…
The Senate of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has announced the establishment of…
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the launch of the SeqCap Epi Target Enrichment System for DNA methylation a…
After successfully launching the PraenaTest of its subsidiary LifeCodexx, Europe's leading service provider of DNA-seque…
Promoter hypermethylation is a frequent mechanism for the repression of gene transcription in cancer and is regarded as…
. - The Epi proLung BL Reflex Assay complements conventional diagnostic methods - Test may identify cancers otherwise…
Epigenomics AG (Frankfurt, Prime Standard: ECX), ein molekulardiagnostisches Unternehmen, das Krebstests auf der Basis…
Das Molekulardiagnostik-Unternehmen Epigenomics AG (Frankfurt, Prime Standard: ECX), das Tests basierend auf DNA-Methyli…
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA), ein führender Anbieter molekulardiagnostischer Produkte und…
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA), a leading provider of molecular diagnostics products and the…